Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil for chronic rhinosinusitis with nasal polyps
IRCT20191014045107N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing Verapamil plus routine treatment with Placebo plus routine treatment (2 arms). Primary endpoint: SNOT-22 questionnaire score. Started Oct 2019; status: completed.
02
Drugs
verapamil
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20191014045107N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191014045107N1.